however, the contradictions between the reports are evident
Mouth Ulcers and Thrush: A dry mouth can weaken the immune defence inside the mouth, making fungal infections like oral thrush more likely
Safety Profile The safety profile of the triple agonist class is consistent with the known GLP-1R agonist class profile, with gastrointestinal adverse events (nausea, vomiting, diarrhea, constipation) being the most frequently reported and typically most prominent during dose escalation before diminishing with continued administration
This pilot is designed to create a more affordable pathway for people who need these treatments while broader, long-term coverage options are being finalized
Because quality can vary widely by pharmacy, the FDA advises doctors to only prescribe compounded tirzepatide when an FDA-approved medication cant meet the patients specific medical needs